Refine your search with our Advanced Search Tool
Listing contains 128 trial(s)
Brain Tumor, Adult: Brain Stem Glioma
Phase I
Phase I Trial of Aflibercept (VEGF Trap) with Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients with Malignant Glioma (NABTC07-01) Study Number: 08-062 |
Brain Tumor, Adult: General & Other
Phase II
A Phase II Trial of PEG Interferon alfa-2b (PEG Intron) for Plexiform Neurofibromas Study Number: 06-116 |
Brain Tumor, Adult: Glioblastoma
Phase I/II
Phase I/II Studies of BAY 43-9006 (Sorafenib) in Combination with OSI-774 (Erlotinib) R115777 (Tipifarnib) or CCI-779 (Temsirolimus) in Patients with Recurrent Glioblastoma Multiforme or Gliosarcoma (NABTC 05-02) Study Number: 06-069 |
Phase II
A Prospective, Multi-center Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients with Newly Diagnosed GBM Study Number: 08-134 |
Phase III
PHASE III DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF CONVENTIONAL CONCURRENT CHEMORADIATION AND ADJUVANT TEMOZOLOMIDE PLUS BEVACIZUMAB VERSUS CONVENTIONAL CONCURRENT CHEMORADIATION AND ADJUVANT TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA Study Number: 09-029 |
About This Web Site
|
Give Us Your Feedback
|
Privacy Statement
|
Disclaimer
|
Informatics Web Resources
©
UPMC, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
412-647-2811
|
PCI-INFO@upmc.edu
|
Send questions and comments to UPCIwebupdates@upmc.edu
